My PSA is rising, although relatively low at 0.68 from undetectable 4 months earlier. Recent CT and bone scans (8/20) were clear.
Trying to get PSMA scan in NY/NJ area, but only option so far is at MSK for $7000 cost. Applied for NIH and Weill Cornell trials, but no spots available. Hope that FDA approval will happen soon and PSMA scans will become widely available.
Have not been treated with chemo yet, unless Olaparib (started Feb 19 and still on it so far) falls under this category. Had also been treated with Zytiga (6 mos), RP, Provenge, and ongoing ADT. Originally diagnosed 5/19, Gleason 10, BRCA2.+, MSS, low tumor burden, clear surgical margins.
Thinking about next treatment options. Oncologist says chemo not in my immediate future. I may want to consider a new Keytruda trial specifically for BRCA2+ patients. Although I read that Keytruda can negatively affect thyroid and adrenal glands. Expect to have updated Auximin scan once PSA exceeds 1.0.
Just in case, I have read that Cabazetaxel is possibly better tolerated than Docetaxel, being less toxic and with fewer side effects?